ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 85 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $206,653 | -55.3% | 166,656 | -62.1% | 0.00% | – |
| Q4 2023 | $461,896 | -85.4% | 439,901 | -4.4% | 0.00% | -100.0% |
| Q3 2023 | $3,153,144 | +51.0% | 460,313 | +128.5% | 0.00% | 0.0% |
| Q2 2023 | $2,088,694 | +136326.8% | 201,417 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $1,531 | -51.8% | 189,261 | -6.1% | 0.00% | 0.0% |
| Q4 2022 | $3,175 | -99.9% | 201,597 | -9.0% | 0.00% | 0.0% |
| Q3 2022 | $3,485,000 | -0.4% | 221,424 | -11.7% | 0.00% | 0.0% |
| Q2 2022 | $3,500,000 | -31.7% | 250,714 | -21.0% | 0.00% | -50.0% |
| Q1 2022 | $5,122,000 | +16.6% | 317,540 | +5.1% | 0.00% | +100.0% |
| Q4 2021 | $4,393,000 | -11.1% | 302,156 | +11.1% | 0.00% | -50.0% |
| Q3 2021 | $4,941,000 | +53.1% | 272,090 | +48.0% | 0.00% | +100.0% |
| Q2 2021 | $3,227,000 | +2706.1% | 183,787 | +67.1% | 0.00% | – |
| Q1 2020 | $115,000 | -39.8% | 110,000 | +8.7% | 0.00% | – |
| Q4 2019 | $191,000 | +52.8% | 101,151 | -12.4% | 0.00% | – |
| Q3 2019 | $125,000 | -55.4% | 115,438 | -9.8% | 0.00% | – |
| Q2 2019 | $280,000 | – | 127,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,399,034 | $49,422,000 | 10.17% |
| VR Adviser, LLC | 4,563,962 | $66,360,000 | 9.07% |
| COMMODORE CAPITAL LP | 2,672,346 | $38,856,000 | 9.00% |
| TCG Crossover Management, LLC | 1,082,213 | $15,735,000 | 7.37% |
| Foresite Capital Management V, LLC | 1,258,243 | $18,295,000 | 4.50% |
| Parkman Healthcare Partners LLC | 1,025,522 | $14,911,000 | 3.29% |
| Aisling Capital Management LP | 634,455 | $9,225,000 | 3.25% |
| GREAT POINT PARTNERS LLC | 800,000 | $11,632,000 | 2.58% |
| Samsara BioCapital, LLC | 794,171 | $11,547,000 | 2.24% |
| Affinity Asset Advisors, LLC | 400,000 | $5,816,000 | 2.11% |